Clinical and Experimental Allergy

Papers
(The H4-Index of Clinical and Experimental Allergy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Featured Cover91
Are paediatric allergy services promoting or harming public health?72
Cluster analysis of nasal cytokines during rhinovirus infection identifies different immunophenotypes in both children and adults with allergic asthma65
Eosinophil‐derived neurotoxin reference values in asthma: The way forward50
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series42
Optimal ImmunoCAP Aspergillus fumigatus‐Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study37
Molecular profile of specific IgE to allergenic components in allergic adults using allergen nano‐bead array36
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab35
Association between long‐term occupational exposure to PM10 and allergic diseases in subway workers34
Nutritional disorders prevalence among adults with immunoglobin E‐mediated food allergy31
Cochrane corner: Pulmonary rehabilitation for adults with asthma31
Anthropological and sociological perspectives on food allergy29
Poor head growth and developmental delay in infants with eczema, food allergies and growth faltering29
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy26
Ara h 2 105‐124 ‐Specific TH2A Cells Drive Peanut Allergy in DRB1*15:01 Individuals: A Detailed Epitope Analysis26
Atopic sensitization in childhood depends on the type of green area around the home in infancy25
Clustering of the Bronchial Epithelial Immune Response to Viral Stimulation in Patients With Asthma Identifies Clinically Recognisable Epithelial Exacerbation Response Profiles25
Recombinant T‐cell epitope conjugation: A new approach for Dermatophagoides hypoallergen design24
Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders24
British Society for Allergy and Immunology (BSACI) Abstracts of the 2023 UK Conference (5–7 October, Harrogate Convention Centre, Harrogate, UK)22
Patients with piperacillin–tazobactam allergy labels tolerate other beta‐lactams22
Temporal Trends in the Course and Management of Chronic Urticaria at a European Tertiary Center22
0.089400053024292